SWEDISH ORPHAN BIOVITRUM ABSWEDISH ORPHAN BIOVITRUM ABSWEDISH ORPHAN BIOVITRUM AB

SWEDISH ORPHAN BIOVITRUM AB

No trades
See on Supercharts
Market capitalization
‪87.87 B‬SEK
‪2.41 B‬SEK
‪22.12 B‬SEK
‪181.34 M‬
Beta (1Y)
0.58

About SWEDISH ORPHAN BIOVITRUM AB

CEO
Guido Oelkers
Headquarters
Solna
Website
Employees (FY)
‪1.77 K‬
Founded
2001
ISIN
SE0000872095
FIGI
BBG000C3YBT6
Swedish Orphan Biovitrum AB engages in the research, development, manufacture, and sale of pharmaceuticals. It operates through the Haematology, Immunology, and Specialty Care segments. The Haemotology segment focuses on haemophilia medicines Elocta and Alprolix. The immunology segment offers treatment for serious, disabling, and life-threatening diseases. The Specialty Care segment specializes in the treatment of genetic and metabolic diseases. The company was founded in 2001 and is headquartered in Solna, Sweden.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of SOBI is 257.80 SEK — it has increased by 0.78% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange SWEDISH ORPHAN BIOVITRUM AB stocks are traded under the ticker SOBI.
SWEDISH ORPHAN BIOVITRUM AB is going to release the next earnings report on Apr 25, 2024. Keep track of upcoming events with our Earnings Calendar.
One year price forecast for SWEDISH ORPHAN BIOVITRUM AB has a max estimate of 370.00 SEK and a min estimate of 285.00 SEK.
SOBI earnings for the last quarter are 0.54 SEK whereas the estimation was 0.37 SEK which accounts for 46.77% surprise. Estimated earnings for the next quarter are 3.58 SEK. See more details about SWEDISH ORPHAN BIOVITRUM AB earnings.
SWEDISH ORPHAN BIOVITRUM AB revenue for the last quarter amounts to ‪5.17 B‬ SEK despite the estimated figure of ‪4.55 B‬ SEK. In the next quarter revenue is expected to reach ‪6.80 B‬ SEK.
Yes, you can track SWEDISH ORPHAN BIOVITRUM AB financials in yearly and quarterly reports right on TradingView.
SOBI stock has fallen by 0.54% compared to the previous week, the month change is a 4.66% fall, over the last year SWEDISH ORPHAN BIOVITRUM AB has showed a 0.33% increase.
Like other stocks, SOBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SWEDISH ORPHAN BIOVITRUM AB stock right from TradingView charts — choose your broker and connect to your account.
SOBI reached its all-time high on Feb 1, 2024 with the price of 302.00 SEK, and its all-time low was 10.88 SEK and was reached on Nov 23, 2011.
See other stocks reaching their highest and lowest prices.
As of Apr 18, 2024, the company has ‪1.77 K‬ employees. See our rating of the largest employees — is SWEDISH ORPHAN BIOVITRUM AB on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. SWEDISH ORPHAN BIOVITRUM AB EBITDA is ‪7.41 B‬ SEK, and current EBITDA margin is 35.37%. See more stats in SWEDISH ORPHAN BIOVITRUM AB financial statements.